Thursday, August 14, 2025
12:00 pm – 1:00 pm CT / 1:00 pm – 2:00 pm ET
Register
Cost: FREE for SIDP Members! $10 for non-member attendees
Invasive fungal infections including mucormycosis, aspergillosis, and candidemia are associated with high mortality and poor outcomes. Treatment is often complicated by increasing antifungal resistance, drug-drug interactions, and sub-optimal pharmacokinetics. Combination antifungal therapy has been explored as a strategy to enhance efficacy, broaden spectrum of activity, and overcome resistance.
The goal of the session is to enhance the ability of pharmacists to optimize treatment of invasive fungal infections through evidence-based use of combination antifungal therapy an informed evaluation of novel antifungal agents.
Target Audience:
This activity was planned to meet the educational needs of pharmacists practicing in adult and pediatric settings; ID-specialized pharmacists; critical care-, transplant-, and oncology-specialized pharmacists
Learning Objectives:
- Evaluate current treatment strategies and clinical evidence supporting the use of combination antifungal therapy for invasive fungal infections
- Describe the pharmacologic properties, mechanisms of action, and spectrum of activity of the novel antifungal agents in late-stage development and recently FDA approved
- Identify clinical scenarios in which combination antifungal therapy may improve outcomes in patients with invasive fungal infections
- Apply emerging antifungal agents and combination therapy considerations to optimize treatment regimens in clinical scenarios
Faculty:
Kayla Stover, PharmD, BCIDP, FCCP, FIDSA
Assistant Dean-Jackson; Vice Chair and Professor
Pharmacy Practice
University of Mississippi School of Pharmacy
Jackson, MS
Josh Clement, PharmD, BCIDP, AAHIVP
Clinical Pharmacy Manager - Infectious Diseases
New York - Presbyterian Hospital
Columbia University Irving Medical Center
New York, NY
Accreditation:
Pharmacist
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0672-0000-25-014-L01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Application
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10
To receive CE credit, participants must view the CE content, complete a post-test with a passing score of 70% or greater, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.
Funding:
This activity is provided by SIDP. No external funding was received for this activity.
Disclosures:
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:
- Dr. Stover's and Dr Clement's disclosures will be announced prior to the start of the activity.
- SIDP planners, staff and other individuals who are in a position to control the content of this CE activity have no relevant financial relationships with an ineligible company to disclose.
- Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human.
Disclaimer:
Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.
The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.
.gif){kind=logo}